Cargando…
Targeted Therapy and Immunotherapy for Melanoma in Japan
Melanoma has several clinically and pathologically distinguishable subtypes, which also differ genetically. Mutation patterns vary among different melanoma subtypes, and efficacy of immune-checkpoint inhibitors differs depending on the subtype of melanoma. In spite of the recent revolution of system...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344396/ https://www.ncbi.nlm.nih.gov/pubmed/30675668 http://dx.doi.org/10.1007/s11864-019-0607-8 |